MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA. 2021;71(1):7–33.
   Google Scholar
• Wang S, Sun H, Xie Z, et al. Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012. Oncotarget. 2016;7(37):59820–59833. doi:10.18632/oncotarget.10930
   PubMedGoogle Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2021;71(3):209–249. doi:10.3322/caac.21660
   Web of Science ®Google Scholar
• Liu T, Long Q, Li L, et al. The NRF2-dependent transcriptional axis, XRCC5/hTERT drives tumor progression and 5-Fu insensitivity in hepatocellular carcinoma. Mol Ther Oncolytics. 2022;24:249–261. doi:10.1016/j.omto.2021.12.012
   PubMed Web of Science ®Google Scholar
• Chen T, Dai X, Dai J, et al. AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway. Cell Death Dis. 2020;11(10):822. doi:10.1038/s41419-020-03030-7
   PubMed Web of Science ®Google Scholar
• Qi F, Zhou A, Yan L, et al. The diagnostic value of PIVKA-II, AFP, AFP-L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma. J Clin Lab Anal. 2020;34(5):e23158. doi:10.1002/jcla.23158
   PubMed Web of Science ®Google Scholar
• Liu Z, Wu M, Lin D, Li N. Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma. J Int Med Res. 2020;48(2):300060520902575. doi:10.1177/0300060520902575
   PubMed Web of Science ®Google Scholar
• Zhang C, Yang Y, Wang K, et al. The systematic analyses of RING finger gene signature for predicting the prognosis of patients with hepatocellular carcinoma. J Oncol. 2022;2022:2466006. doi:10.1155/2022/2466006
   PubMed Web of Science ®Google Scholar
• Ge S, Huang H, Huang W, et al. PSME4 activates mTOR signaling and promotes the malignant progression of hepatocellular carcinoma. Int J Gen Med. 2022;15:885–895. doi:10.2147/IJGM.S344360
   PubMed Web of Science ®Google Scholar
• Huang X, Wang H, Xu F, et al. Overexpression of chaperonin containing TCP1 subunit 7 has diagnostic and prognostic value for hepatocellular carcinoma. Aging. 2022;14(2):747–769. doi:10.18632/aging.203809
   PubMedGoogle Scholar
• Chen M, Zhang C, Liu W, Du X, Liu X, Xing B. Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming. Mol Ther. 2022;30(6):2354–2369. doi:10.1016/j.ymthe.2022.02.020
   PubMed Web of Science ®Google Scholar
• Yang Y, Ren P, Liu X, et al. PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition. J Exp Clin Cancer Res. 2022;41(1):101. doi:10.1186/s13046-022-02302-8
   PubMed Web of Science ®Google Scholar
• Wei XC, Liu LJ, Zhu F. Exosomes as potential diagnosis and treatment for liver cancer. World J Gastrointest Oncol. 2022;14(1):334–347. doi:10.4251/wjgo.v14.i1.334
   PubMed Web of Science ®Google Scholar
• Wu WC, Walaas SI, Nairn AC, Greengard P. Calcium/phospholipid regulates phosphorylation of a Mr “87k” substrate protein in brain synaptosomes. Proc Natl Acad Sci U S A. 1982;79(17):5249–5253. doi:10.1073/pnas.79.17.5249
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang W, Selmi C, et al. The myristoylated alanine-rich C-kinase substrates (MARCKS): a membrane-anchored mediator of the cell function. Autoimmun Rev. 2021;20(11):102942. doi:10.1016/j.autrev.2021.102942
   PubMed Web of Science ®Google Scholar
• Mitra A, Yoshida-Court K, Solley TN, et al. Extracellular vesicles derived from ascitic fluid enhance growth and migration of ovarian cancer cells. Sci Rep. 2021;11(1):9149. doi:10.1038/s41598-021-88163-1
   PubMed Web of Science ®Google Scholar
• Manai M, Abdeljaoued S, Goucha A, et al. MARCKS protein overexpression is associated with poor prognosis in male breast cancer. Cancer Biomark. 2019;26(4):513–522. doi:10.3233/CBM-190637
   PubMed Web of Science ®Google Scholar
• Liu J, Chen SJ, Hsu SW, et al. MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer. Theranostics. 2021;11(9):4122–4136. doi:10.7150/thno.53558
   PubMed Web of Science ®Google Scholar
• Wu F, Chen W, Kang X, et al. A seven-nuclear receptor-based prognostic signature in breast cancer. Clin Transl Oncol. 2020;23:1292–1303. doi:10.1007/s12094-020-02517-1
   PubMed Web of Science ®Google Scholar
• Kim YE, Kim EK, Song MJ, Kim TY, Jang HH, Kang D. SILAC-based quantitative proteomic analysis of oxaliplatin-resistant pancreatic cancer cells. Cancers. 2021;13(4). doi:10.3390/cancers13040724
   Web of Science ®Google Scholar
• Naboulsi W, Megger DA, Bracht T, et al. Quantitative tissue proteomics analysis reveals versican as potential biomarker for early-stage hepatocellular carcinoma. J Proteome Res. 2016;15(1):38–47. doi:10.1021/acs.jproteome.5b00420
   PubMed Web of Science ®Google Scholar
• Ren X, Ju Y, Wang C, Wei R, Sun H, Zhang Q. MARCKS on tumor-associated macrophages is correlated with immune infiltrates and poor prognosis in hepatocellular carcinoma. Cancer Invest. 2021;39(9):756–768. doi:10.1080/07357907.2021.1950757
   PubMed Web of Science ®Google Scholar
• Ni W, Bian S, Zhu M, et al. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma. Front Oncol. 2021;11:629327. doi:10.3389/fonc.2021.629327
   PubMedGoogle Scholar
• Tohme S, Yazdani HO, Rahman A, et al. The use of machine learning to create a risk score to predict survival in patients with hepatocellular carcinoma: a TCGA cohort analysis. Can J Gastroenterol Hepatol. 2021;2021:5212953. doi:10.1155/2021/5212953
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi:10.1038/s41467-019-09234-6
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–d613. doi:10.1093/nar/gky1131
   PubMed Web of Science ®Google Scholar
• Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape stringapp: network analysis and visualization of proteomics data. J Proteome Res. 2019;18(2):623–632. doi:10.1021/acs.jproteome.8b00702
   PubMed Web of Science ®Google Scholar
• Zhou Q, Yan X, Liu W, et al. Three immune-associated subtypes of diffuse glioma differ in immune infiltration, immune checkpoint molecules, and prognosis. Front Oncol. 2020;10:586019. doi:10.3389/fonc.2020.586019
   PubMed Web of Science ®Google Scholar
• Hanko M, Grendár M, Snopko P, et al. Random forest-based prediction of outcome and mortality in patients with traumatic brain injury undergoing primary decompressive craniectomy. World Neurosurg. 2021;148:e450–e458. doi:10.1016/j.wneu.2021.01.002
   PubMed Web of Science ®Google Scholar
• Núñez E, Steyerberg EW, Núñez J. Estrategias para la elaboracio´n de modelos estadı´sticos de regresio´n [Regression modeling strategies]. Rev Esp Cardiol. 2011;64(6):501–507. Spanish. doi:10.1016/j.recesp.2011.01.019
   PubMed Web of Science ®Google Scholar
• Kim J, Kaufman JS, Bang H. Graphing ratio measures on forest plot. J Am Coll Cardiol. 2018;71(5):585–586. doi:10.1016/j.jacc.2017.10.098
   PubMed Web of Science ®Google Scholar
• Iyer DN, Faruq O, Zhang L, Rastgoo N, Liu A, Chang H. Pathophysiological roles of myristoylated alanine-rich C-kinase substrate (MARCKS) in hematological malignancies. Biomark Res. 2021;9(1):34. doi:10.1186/s40364-021-00286-9
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang J, Zhou G. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma. J Oral Pathol Med. 2020;2020:1.
   Google Scholar
• Beckmann L, Berg V, Dickhut C, et al. MARCKS affects cell motility and response to BTK inhibitors in CLL. Blood. 2021;138(7):544–556. doi:10.1182/blood.2020009165
   PubMed Web of Science ®Google Scholar
• Mohapatra P, Yadav V, Toftdahl M, Andersson T. WNT5A-induced activation of the protein kinase C substrate MARCKS is required for melanoma cell invasion. Cancers. 2020;12(2):346. doi:10.3390/cancers12020346
   PubMed Web of Science ®Google Scholar
• Castven D, Czauderna C, Becker D, et al. Acquired resistance to antiangiogenic therapies in hepatocellular carcinoma is mediated by yes-associated protein 1 activation and transient expansion of stem-like cancer cells. Hepatol Commun. 2021;6:1140–1156. doi:10.1002/hep4.1869
   PubMed Web of Science ®Google Scholar
• Chavez-Dominguez R, Perez-Medina M, Aguilar-Cazares D, et al. Old and new players of inflammation and their relationship with cancer development. Front Oncol. 2021;11:722999. doi:10.3389/fonc.2021.722999
   PubMed Web of Science ®Google Scholar
• Lin W, Zhang HL, Niu ZY, et al. The disease stage-associated imbalance of Th1/Th2 and Th17/Treg in uterine cervical cancer patients and their recovery with the reduction of tumor burden. BMC Womens Health. 2020;20(1):126. doi:10.1186/s12905-020-00972-0
   PubMed Web of Science ®Google Scholar
• Lenehan PJ, Cirella A, Uchida AM, et al. Type 2 immunity is maintained during cancer-associated adipose tissue wasting. Immunol Adv. 2021;1(1):ltab011. doi:10.1093/immadv/ltab011
   Google Scholar
• Wang S, Ma H, Li X, et al. DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection. Aging. 2020;12(2):1171–1185. doi:10.18632/aging.102675
   PubMedGoogle Scholar
• Tayob N, Kanwal F, Alsarraj A, Hernaez R, El-Serag HB. The Performance of AFP, AFP-3, DCP as biomarkers for detection of Hepatocellular Carcinoma (HCC). A Phase 3 biomarker study in the United States. Clin Gastroenterol Hepatol. 2022;2020:1.
   Google Scholar